Medicare

UnitedHealth stock extends slide after bell as Medicare Advantage deadline nears
···

Il titolo di UnitedHealth continua a scendere dopo la chiusura mentre si avvicina la scadenza per Medicare Advantage

UnitedHealth Group ha perso il 2,6% a $273,95 nell’after-hours di martedì, ampliando un calo di due giorni pari al 5,5%. Il titolo è sotto pressione mentre gli investitori attendono la chiusura della finestra per i commenti sulle tariffe Medicare Advantage 2027, prevista per mercoledì. Anche Humana, Elevance e CVS Health hanno chiuso in ribasso, nonostante i rialzi di S&P 500 e Dow.
Febbraio 25, 2026

Stock Market Today

  • EMVision Advances Rural Stroke Detection with Successful Aeromedical Feasibility Study
    May 27, 2026, 12:57 AM EDT. EMVision Medical Devices (ASX: EMV) completed a critical feasibility study of its First Responder Brain Scanner in aeromedical conditions with the Royal Flying Doctor Service, proving device usability and scan data integrity during flights up to 371km. The study enrolled 17 adults, showing positive patient experience and strong operator feedback. Scan times averaged just over 5 minutes, supporting swift stroke assessment in remote areas. This progress de-risks regulatory approval pathways by validating data quality in real-world emergency settings. EMVision also received a $400,000 non-dilutive milestone payment via the Australian Stroke Alliance, building on $18.4 million cash reserves. The company prepares for expanded pre-hospital trials and commercial device production, targeting stroke diagnosis outside hospitals despite challenges including complex clinical trials and funding continuity.